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ABSTRACT 
Cheedu , Divya. M.S. Department of Biological Sciences, Wright 
State University, 2016. Regulation of Mitotic progression by Btf and 
TRAP150. 
Serine-arginine-rich (SR) or SR-like splicing factors interact with exon junction 
complex proteins during pre-mRNA processing to promote mRNA packaging into 
mature messenger ribonucleoproteins (mRNPs) and to dictate mRNA stability, 
nuclear export, and translation. In this thesis, I examined if depletion of two 
homologous non-classical serine-arginine-rich (SR) splicing factors, Btf (BCLAF1) 
and TRAP150, impacts regulation of cell cycle regulator transcripts and mitosis. 
Previous work showed that depletion of these proteins by RNAi causes mitotic 
defects including chromosome misalignment in metaphase. However, since Btf 
and/or TRAP150 did not co-localize with mitotic structures during mitosis, I 
hypothesized that Btf and/or TRAP150 depletion affect mitosis indirectly through 
altered expression of mitotic regulator transcripts. My results indicated that Btf and 
TRAP150 are important for controlling the abundance of transcripts that encode 
mitotic regulators. My results also suggest that Btf and TRAP150 have increased 
effects in maintaining the alignment of chromosomes at metaphase, as co-depletion 
of Btf and TRAP150 showed increased effects on the misalignment of 
chromosomes, thus demonstrating an important role in mitotic progression. Future 
studies will determine if altered expression or processing of endogenous cell cycle 
regulator protein transcripts is a result of changes in transcript distribution, and they 
will tease apart the molecular mechanisms underlying defective mitotic 
chromosome alignment/segregation in absence of Btf and TRAP150. 
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CHAPTER 1: SIGNIFICANCE AND BACKGROUND 
1.1 INTRODUCTION 
Expression of protein coding genes requires an organized series of events starting 
with transcription of genes into pre-mRNA, pre-mRNA processing, mRNA nuclear 
export and translation of mature mRNAs. Pre-mRNA processing steps occur co-
transcriptionally, including 5’ capping, pre-mRNA splicing and 3’ 
cleavage/polyadenylation prior to nuclear export, followed by translation and protein 
folding in the cytoplasm (Figure 1) (Reinberg, 2002; Rodríguez-Navarro S, 2011). 5’ 
capping of pre-mRNA involves addition of 7-methylguanosine to the 5’end as 
phosphatase removes the terminal 5’ phosphate and guanylyltransferase adds 7-
methylguanosine using GTP. A complex of protein/RNA subunits assembled stepwise 
into a spliceosome that removes introns and precisely ligates exons catalyzes pre-mRNA 
splicing. Alternative splicing generates different isoforms of pre-mRNA by either 
inclusion or exclusion of introns/exons in the mature mRNA. Alternative splicing is a 
regulated process that results in multiple proteins being expressed from a single gene, 
often in a manner that allows expression of different isoforms in different cell types. Four 
categories of splicing regulatory sequences allow alternative splice site selection, 
including exon splicing enhancers (ESEs), exon splicing silencers (ESSs), intron splicing 
enhancers (ISEs) and intron splicing silencers (ISSs)  (Black, 2003).  SR protein 
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recognition of splicing enhancer and silencer elements mediates splice site selection 
during alternative splicing (Blencowe et al., 1999; Sanford et al., 2004).  
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Figure 1.  A contemporary theory of gene expression 
Coupling of gene expression events ensures that no step of gene expression is 
omitted. This organization of events introduces a series of quality control mechanisms. 
The various steps of co-transcriptional processes include 5’ capping, splicing, cleavage 
and polyadenylation. Mature mRNA is then exported to the cytoplasm through nuclear 
pores via exon junction complex proteins (in green circles). The process of translation 
and protein folding then occurs in the cytoplasm (Reinberg, 2002). 
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(Reinberg, 2002) 
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Pre-mRNA transcription is coupled to –pre-mRNA processing on a specialize 
subunit of RNA polymerase II (RNApolII) that has a long carboxy-terminal domain 
(CTD) comprised of a repeating consensus heptapeptide sequence ‘YSPTSPS’. The 
RNApolII CTD is dynamically hyperphosphorylated during transcription initiation and 
during the conversion of RNApolII to elongation phase of transcription. The arginine-
serine (RS) domain of SR proteins interacts with the hyperphosphorlated RNApolII CTD 
during transcription elongation (Zhong et al., 2009; Blencowe et al., 1999). SR or SR-like 
proteins also interact with the exon junction complex during mRNA processing events 
and promote packing into mature ribonucleoprotein (mRNP) (Figure 2) (Katahira. J 
2015). 
 Assembling of mRNP begins at pre-mRNA transcription and proceeds to form a 
mature mRNP during several processing events. These RNA- protein interactions are 
very important in understanding the fidelity and accuracy of gene expression (Singh et 
al., 2012). A major player in signaling mRNA maturation and the most prominent protein 
complex that constitutes mRNP is the exon junction complex (EJC), a multiprotein 
complex that is deposited upstream of mRNA exon-exon junctions during the process of 
splicing. EJC core proteins include Y14, Magoh, eIF4Aiii, and MLN51, and this core 
EJC complex provides a connecting platform for other EJC accessory proteins that 
participate in splicing process (Figure 3) (Singh et al., 2012). My thesis focuses on 
understanding the function of two homologous nuclear speckle SR-like proteins - Btf and 
TRAP150 – in regulation of cell cycle regulator protein transcripts.  Both of these 
proteins have been noted previously as EJC accessory proteins (see Figure 3) 
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Figure 2: Splicing changes the structure and the composition of an mRNP. 
The exon-junction complex (EJC) and a subset of SR proteins are deposited on 
the mRNP upon splicing. Multimerization of the EJC along with the associated SR 
proteins promotes mRNP packaging and compaction. Splicing also recruits TREX  
(transcription export complex) to the 5’ end of mRNA (Katahira, J. 2015). 
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 (Katahira.J 2015) 
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Figure 3: The cellular EJC interactome reveals higher order mRNP 
structure and an EJC-SR protein nexus. 
The EJC interactome and a new view of mRNP structure: Solid black line: exonic 
RNA; Dashed black line: a generic intron; Color ovals: proteins enriched more >10-fold 
in the EJC proteome listed in descending order of stoichiometry. Black ovals: undetected 
proteins known to bind to mRNA ends; Green spheres: bridging protein-protein 
interactions (Singh et al., 2012). 
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                (Singh et al., 2012) 
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Capping, splicing and 3’ polyadenylation of the mRNA must occur prior to 
nuclear export, and mRNP composition can affect the stability and translation of mRNA. 
Pre-mRNA processing events are highly coordinated and organized into nuclear 
organelles, sub-nuclear structures where nuclear factors having common functions 
colocalize to undergo complex maturation or to perform a subset of functions. Nuclear 
domains identified so far include nuclear speckles, promyelocytic leukemia bodies 
(PML), perichromatin fibrils, Cajal bodies, paraspeckles and others (Figure 4) (Spector, 
2001). Splicing factors reside interspersed between regions of chromatin, and by 
transmission electron microscopy appear as clusters of granules or “interchromatin 
granule clusters” (IGCs) but more commonly are known as nuclear speckles (Gall et al., 
1999) that will be discussed in the next chapter.  
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Figure 4: A schematic diagram of various nuclear domains in the 
mammalian cell nucleus (Spector, 2001). 
This is a schematic diagram of a mammalian cell nucleus. Various non-membrane 
bound nuclear domains were identified based on their immunolocalization pattern and 
function such as PcG body, Cajal body, Gem, PML body, nucleolus, nuclear speckles and 
others. 
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(Spector, 2001) 
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1.2 Nuclear speckles: 
Pre-mRNA processing factors localize in small domains of the nucleus called 
nuclear speckles (Spector 1993). Speckles are highly dynamic structures and their size, 
shape and number are dependent on the level of gene expression within a particular cell 
(Misteli, 2000). The nuclear speckles do not contain DNA, so active transcription does 
not occur within speckles but are in close proximity with transcription sites (Huang and 
Spector, 1991; Thiry, 1995). This location of speckles in close proximity with 
transcription sites suggests a role for speckles in gene expression. Proteomic analysis of 
nuclear speckles revealed the presence of at least 180 proteins, many of which are 
involved in pre-mRNA processing (Mintz et al., 1999; Saitoh et al., 2004). Proteomic 
analysis also revealed 33 novel speckle proteins that remain to be functionally 
characterized (Mintz et al., 1999; Saitoh et al., 2004). 
Proteomic analysis of nuclear speckles revealed that speckles are enriched with 
pre-mRNA splicing factors, snRNPs (small ribonuclear protein particles), SR proteins 
(serine-arginine rich proteins) and the large subunit of RNA polymerase II (Saitoh et al., 
2004). Phosphorylation regulates the shuttling of these pre-mRNA processing factors 
between speckles and pre-mRNA transcripts. Phosphorylation of SR proteins signals 
splicing factors to be recruited to transcription sites, and dephosphorylation signals the 
splicing factors to return to the speckles (Mintz et al., 1999; Misteli and Spector, 1996). 
My project aims to understand how normal mitosis requires two SR-like nuclear speckle 
proteins, Btf and TRAP150, for pre-mRNA processing of specific transcripts encoding 
proteins that drive progression of mitosis. 
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1.3 SR Proteins 
SR proteins were initially identified as nuclear RNA-binding proteins with 
domain rich in serine and arginine residues that are phylogenetically conserved across 
vertebrates and invertebrates. Classical SR proteins contain one or more RNA-
recognition motifs also called RNA binding domains at the N-terminus and 
serine/arginine rich domains at the C-terminus that mediates protein-protein interactions 
in nuclear speckles as well as to recruit splicing factors during assembly of spliceosome 
complex (Kohtz et al., 1994: Wu and Maniatis, 1993). The entire family of SR proteins 
plays an important role in gene expression, as splicing factors and as regulators of 
splicing, mRNA export, mRNA stability and quality control (Manley and Krainer, 2010).  
 
1.4 Btf and TRAP150 
             Btf has been previously described as a Bcl2-associated transcription factor and a 
nuclear speckle protein with RS domain at its N-terminus (Kasof et al., 1999; Saitoh et 
al., 2004; Mintz et al., 1999). Btf was shown to be involved in apoptosis by interacting 
with E1B 19K, a homologue of Bcl-2 (Kasof et al., 1999). Overexpression of Btf in HeLa 
cells induced apoptosis, which was inhibited by E1B 19K, a sequence and functional 
homologue of anti-apoptotic gene product Bcl2 (Kasof et al., 1999). It was not 
determined if the interaction of Btf and E1B 19K was necessary for the ability of these 
anti-apoptotic factors to suppress the pro-apoptotic or transcriptional repression activities 
of Btf.  TRAP150 is a thyroid hormone receptor associated protein of 150 kDa, first 
identified as a component of nuclear receptor, TRAP complex (Ito et al., 1999; Rachez 
and Freedman, 2001).  
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Btf and TRAP150 are non-classical SR-like proteins that have a characteristic RS 
domain (repeated serine-arginine residues) at the N-terminus (residues 1-148 in Btf; 
residues 1-165 in TRAP150), unlike classical SR proteins that have a C-terminal RS 
domain. Btf and TRAP150 are highly related to each other, showing 39% sequence 
identity and 66% sequence similarity (Figure 5) (Potabathula, D. 2009). Both of these 
proteins have similar localization patterns and share a high degree of similarity in their 
sequence. The main goal of my thesis was to elucidate the cellular functions of Btf and 
TRAP150, and to understand if Btf and TRAP150 have similar or distinct roles, 
particularly in mRNA metabolism. 
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Figure 5: A graphical representation of the alignment of Btf and TRAP150 
showing regions of similarity (Potabathula, D., 2009) 
Full-length amino acid alignment of TRAP150 and Btf was done using the SIM 
alignment tool at www.expasy.org. This figure shows the graphical representation of the 
alignment. The similarity scale at the top is the color code of % similarity. The resulting 
alignment was viewed as LaLN View in BLAST search. 
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 (Alignment data and figure display were generated using www.expasy.org; 
Potabathula, D., 2009; with assistance from Dr. Scott Baird).  
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1.5 Mitosis 
Mitosis is an essential process of life where cells precisely replicate and divide 
their duplicated genetic material equally between two daughter cells. As cells approach 
mitosis, DNA replication produces two copies of every chromosome, which are, referred 
to as sister chromatids. These sister chromatids are segregated into two daughter cells that 
each receive complete set of chromosomes. Mitosis is divided into prophase, metaphase, 
anaphase and telophase. During early mitosis, chromatin condenses to form 
chromosomes. During prophase, changes in microtubule dynamics result in a loss of 
individual microtubules and microtubule bundles begin to form. Microtubules begin to 
search and capture kinetochores during prometaphase. The cell is considered to be in 
metaphase once all the kinetochores are attached to microtubules and the chromosomes 
align at the metaphase plate. Each chromosome possesses two kinetochores that allow 
them to become stably connected to the spindle poles (Wadsworth, 2004). After all 
chromosomes are oriented on the metaphase plate, segregation to opposite centrosomes 
occurs during anaphase (Haering, 2003). During telophase, the chromosomes begin to 
decondense, the nuclear envelope reassembles, and the mitotic spindle disassembles. 
Toward the end of mitosis, the cytoplasmic components of a cell begin to divide in a 
process known as cytokinesis (Pines, 2006). 
1.6 Spindle assembly checkpoint (SAC) 
              Chromosome segregation during mitosis is crucial for maintaining genomic 
stability. Chromosome segregation during mitosis involves dynamic interactions between 
spindle microtubules and kinetochores. The spindle assembly checkpoint (SAC) regulates 
proper attachment of microtubules to kinetochores and ensures proper tension between 
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the kinetochores of sister chromatids (Musacchio and Salmon, 2007). The SAC ensures 
proper chromosome segregation by preventing anaphase onset until all chromosomes are 
properly attached to microtubules that align chromosomes at the metaphase plate. 
Improperly attached kinetochores emit signals that activate the SAC, which in turn stops 
the cell cycle by negatively regulating CDC20, thereby preventing the activation of the 
anaphase promoting complex (APC). SAC proteins include MAD2/MAD3, BUB3 and 
CDC20 (Sudakin et al., 2001). SAC proteins are also known as mitotic checkpoint 
proteins. Other proteins involved in SAC known as chromosomal passenger proteins are 
MAD1, BUB1, Mps1, Aurora B, INCENP, Survivin, CENP-E and CENP-F (Sudakin et 
al., 2001). During prometaphase, the spindle assembly checkpoint proteins along with 
CDC20 assemble at the kinetochores before attachment to the spindle assembly (Sudakin 
et al., 2001). The major role of SAC proteins is to ensure correct kinetochore-microtubule 
attachments after which they dissemble and activate the APC/C. The spindle assembly 
checkpoint senses unattached kinetochores (Nicklas, 1997). Unattached kinetochores 
recruit a complex of checkpoint proteins, MAD2, BUB3, BubR1, Aurora B, CENP-E and 
CDC20 forming a multi-protein complex. This multi-protein complex inhibits APC/C 
and prevents mitosis from proceeding to anaphase. (Figure 6) (Marques et al. 2015; Shah 
and Cleveland, 2000). When all the kinetochores are properly captured by microtubules, 
tension is detected, the checkpoint is satisfied, and MAD2 is released. This allows 
progression from metaphase to anaphase. 
               SAC regulates transition from metaphase to anaphase of mitosis. Unattached 
kinetochores SAC defects cannot delay mitosis and thus become aneuploid with 
abnormal number of chromosomes (Figure7) (Fisk, 2015). The regulation of SAC 
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proteins is very important for effective cell cycle progression. 
   CENP-E-dependent BubR1 autophosphorylation at unattached kinetochores is 
important for activating the spindle checkpoint to prevent single chromosome loss (Guo 
et al., 2012). CENP-E is required for accurate chromosome congression at metaphase. It 
binds to and regulates the mitotic checkpoint kinase BubR1 at kinetochores (Chan et al., 
1999; Mao et al., 2003). Localization of MAD2 and BubR1 at kinetochores depends on 
Aurora B kinase activity. Aurora B kinase is required for chromosomal condensation, 
chromosomal alignment at metaphase and also has roles in spindle checkpoint (Fu et al., 
2007; Jackson et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
21 
Figure 6: A molecular view of SAC signaling. 
 (A) Unattached kinetochores recruit a complex of checkpoint proteins Bub3, 
BubR1, Cdc20 and Mad2 that inhibits the actions of the APC and activate the SAC (SAC 
ON) preventing degradation of securin and cyclin B thus leading to mitotic arrest. (B). 
Upon attachment of all kinetochores, a proper tension is detected at the SAC, it is turned 
off (SAC OFF) and the checkpoint proteins are released which leads to activation of 
APC/C and mitotic exit. Securin is degraded and separase can now degrade cohesins 
between sister-chromatids and can proceed to anaphase, while cyclin B degradation leads 
to CDK1 inactivation and mitotic exit. 
(Marques et al., 2015) 
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 (Marques et al., 2015) 
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Figure 7: SAC defects promote to aneuploidy 
 
  Normal pathway of spindle assembly checkpoint is represented at the top 
while the defective pathway is represented at the bottom. In the normal pathway, all the 
chromosomes are aligned properly on the metaphase plate and are pulled towards the 
opposite poles of the spindle during the anaphase phase of mitosis. In the defective 
pathway, the chromosomes are either not aligned properly on the metaphase plate or not 
all the chromosomes are pulled towards the spindle. The unattached chromosomes lead to 
the loss or gain of one or more chromosomes that might lead to aneuploidy. SAC must be 
activated to check the proper alignment of chromosomes at metaphase and to prevent the 
onset of anaphase in the chromosomes that are not properly attached to the spindle. Thus 
SAC defects may lead to aneuploidy. 
(Fisk, 2015) 
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The goal of my project was to understand the role of Btf and TRAP150 in cell 
cycle progression through mitosis. The major question is to understand how these two 
homologous proteins, Btf and TRAP150, have similar role in mitosis and act as mitotic 
regulators of the mitotic checkpoint transcripts (at SAC) that are involved in alignment of 
chromosomes at metaphase plate or if they regulate the splicing of major mitotic 
regulators, thus affecting mitosis.  
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CHAPTER 2: HYPOTHESES AND EXPERIMENTAL AIMS  
Aneuploidy is described as a condition with abnormal number of chromosomes 
that may result from improper segregation of sister chromatids during mitosis and this 
can result in the formation of cancer (Weaver et al., 2007). 80% of the tumors are 
aneuploid with either gain or loss of chromosomes (Lengauer et al., 1998). This genetic 
imbalance has effects on gene transcription and translation that results in cell death 
(Torres et al., 2007; Kops et al., 2004). In addition, splicing errors accounts for 15% of 
genetic diseases (Long and Caceres, 2009). Aneuploidy may be a result of deregulation 
of many mitotic genes.  
  Previous results from our lab showed that depletion of Btf/TRAP150 results in 
misalignment of chromosomes at the metaphase plate (Figure 8) that suggests their role 
in mitosis. This led to our hypothesis that Btf and TRAP150 regulate abundance, 
processing and/or cellular distribution of cell cycle regulator transcripts and also suggest 
that Btf and TRAP150 impact mitosis indirectly (rather than directly) by altering cell-
cycle regulator transcripts.  
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Figure 8: Misalignment of chromosomes upon co-depletion of Btf/TRAP150 
depletion 
IMR90 cells were transfected with siRNA duplexes targeting luciferase (control, 
C) or Btf si1 + TRAP150 si4 (BT). 72 hrs post-transfection the cells were processed for 
localization of Btf and TRAP150. DNA was stained with DAPI. Arrow indicates 
misaligned chromosomes.  (A. Bubulya and P. Bubulya, unpublished) 
 
 
 
 
 
 
 
 
 
 
28 
 
 
  
 
 
 
 
 
 
 
 
 
(Dr. Paula Bubulya and Dr. Athanasios Bubulya) 
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Depletion of Btf and TRAP150 in HeLa cells increases the frequency of 
chromosome misalignment at metaphase. I hypothesized that altered abundance of cell 
cycle regulator mRNAs regulate mitotic progression, in particular affecting chromosome 
misalignment. This hypothesis is based on exon microarray studies done previously 
showing that depletion of Btf and TRAP150 results in the alteration of key mitotic 
transcripts required for cell cycle progression. Thus we hypothesize that Btf and 
TRAP150 regulate abundance, processing and/or cellular distribution of cell cycle 
regulator transcripts and also suggest that Btf and TRAP150 impact mitosis indirectly 
(rather than directly) by altering cell-cycle regulator transcripts.  
            Previous work in Bubulya lab showed that Btf/TRAP150 co-localized to the 
greatest extent with SRSF1 and EJC component Magoh at a exogenous inducible gene 
array upon transcription activation, but showed little to no overlap with transcription 
factors at the locus (Varia et al., 2013).  Btf and TRAP150 were also co-
immunoprecipitated with exon junction complex (EJC) proteins (Lee et al., 2010; Varia 
et al., 2013). However, there is not much known about the interacting protein partners of 
Btf andTRAP150. This led to our hypothesis to identify the interacting partners of Btf 
and TRAP150 that may help us to understand common versus distinct pre-mRNA 
processing and other functions of Btf/TRAP150. 
My experimental aims were as follows 
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Aim 1: Validate altered abundance of mitotic regulator protein transcripts 
following Btf and/or TRAP150 depletion  
Aim2: Study mitotic defects after Btf/andTRAP150 depletion 
Aim 2a: Score mitotic index and mitotic defects in cells depleted of Btf 
 and/or TRAP150 
Aim2b: Localization of mitotic checkpoint proteins. 
Aim 3: To identify protein partners of Btf and TRAP150 
2.1 Specific aims 
Aim 1:  Validate regulation of transcript abundance  
In order to validate genes with differential gene expression, qRT-PCR was 
performed on transcripts already identified by human exon array analysis to show altered 
expression level.  My studies focus on a set of six genes (AURK-B, CENP-F. BUB1, 
CDK1, CDC-20 and MAD2L1; function of each gene is shown in Table 1) encoding cell 
cycle regulator transcripts that clearly showed differences between HeLa cells treated 
either with Btf-depleted or TRAP150-depleted compared to HeLa cells treated with 
control luciferase siRNA. This aim helped us to determine that Btf or TRAP150 regulate 
the expression of cell-cycle regulator transcripts as one explanation for defects in mitosis 
and cell cycle progression. 
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Table 1: Function of gene whose transcript is validated using qPCR 
 
GENE FUNCTION 
AURK-B Attachment of mitotic spindle to the centromere 
CENP-F Important in centromere and kinetochore attachment 
BUB1 
Essential for spindle assembly checkpoint signaling and correct 
chromosome alignment 
CDK1 
When bound to cyclin partners, CDK1 phosphorylation leads to cell-
cycle progression 
CDC20 
Activates Anaphase promoting factor, that initiates chromatid 
separation and enters into anaphase 
MAD2L1 
Inhibits Anaphase promoting complex until the chromosomes are 
attached to the spindle 
(shown to be present at the unattached chromosome) 
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Aim 2:  To Study mitotic defects after Btf/andTRAP150 depletion 
Previous results from the Bubulya lab showed no localization of Btf/TRAP150 at 
the mitotic spindle, kinetochores, or any other mitotic structure known to have 
connections to chromosome misalignment. This clearly shows that they are more likely to 
regulate the cell cycle progression indirectly via transcript abundance/processing than 
directly in a mitotic structure. To further study mitotic defects at various stages of mitosis 
upon either Btf or TRAP150 or simultaneous depletion of both Btf and TRAP150, I 
scored HeLa cells after RNAi treatment to score mitotic index and mitotic phase 
distribution in control versus depleted samples.  
Aim2a: Score mitotic index and mitotic defects in cells depleted of Btf 
and/or TRAP150 
 I scored numbers of mitotic cells in each sample as well as the numbers of cells in 
each mitotic phase, and if the mitotic cells displayed normal or abnormal chromosome 
organization. To calculate mitotic distribution, 500 mitotic cells of each sample (3 
replicates performed) were scored and categorized according to different mitotic stages. 
Defective mitotic cells were also scored and categorized. This aim was designed to 
understand if metaphase defects are the most abundant and seen most frequently when 
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Btf or TRAP150 are individually depleted.  I also co-depleted both Btf and TRAP150 to 
determine if this would show increased effects on mitotic index and/or phenotypes.   
Aim2b: Localization of mitotic checkpoint proteins. 
To investigate the role of Btf or TRAP150 in alignment of chromosomes during 
mitosis, I have analyzed the expression and localization of spindle assembly checkpoint 
proteins on Btf/TRAP150 depletion, or Btf and TRAP150 depletion by immunoblot and 
immunofluorescence studies. MAD2, Aurora B and CENP-A were labeled by 
immunofluorescence to determine the abundance of checkpoint proteins at kinetochores. 
I have also determined if expression of the protein products of these genes was affected.  
Aim 3: To identify protein binding partners of Btf and TRAP150 
Immunoprecipitation studies were done in order to identify interacting partners of 
Btf and TRAP150.  Understanding interacting partners help us to understand pre-mRNA 
processing and other functions of Btf and TRAP150 such as cell cycle regulation.  In 
addition, it will be important to identify binding partners that are common to both Btf and 
TRAP150 (involved in functions that are overlapping between these proteins) versus 
those that are distinct and could regulate divergent functions between Btf and TRAP150. 
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CHAPTER 3: MATERIALS AND METHODS 
3.1 Cell Culture 
HeLa cells were maintained in Dulbecco’s Modified Eagles Medium (DMEM) 
supplemented with 1% penicillin/streptomycin and 10% fetal bovine serum. Cells were 
incubated at 37°C and 5% CO2. To passage HeLa cells, they were washed three times 
with phosphate buffered saline (PBS; 137mM NaCl; 2.7mM KCl; 4.3 mM Na2HPO4; 
1.47 mM KH2PO4, pH 7.4). After washing, the cells were incubated with trypsin-EDTA 
(Invitrogen, 0.25% trypsin solution) for 2 minutes at 37°C. Approximately 5 ml of FBS 
in DMEM was added to inactivate the trypsin and the suspension was transferred to a 15 
ml conical tube and centrifuged at 1500 rpm for 2 minutes. The supernatant was removed 
by aspiration and the pellet was resuspended in 5 ml of DMEM. The cells were then 
either plated into new 100 mm X 20 mm culture dishes or counted and plated into 6 well 
dishes for experiments. HeLa cells were grown on the coverslips in Dulbecco's modified 
eagle medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS) and 1% 
penicillin/streptomycin antibiotic for Immunofluorescence experiments. 
  
3.2 Plating Cells 
To plate cells for immunofluorescence experiments, qRT-PCR experiments and siRNA 
depletion experiments, the cells were collected as previously described in the cell culture 
procedure. Ten microliters of the cell suspension was loaded onto each side of a Bright 
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Line hemocytometer. The cells were counted to determine cell concentration. Cells were 
diluted with DMEM to a concentration of 1 X 105 cells/ml. These were plated onto 
coverslips to process for immunofluorescence and without coverslips for protein and 
RNA extraction. 
 
3.3 Freezing and thawing cells 
To freeze the cells, the cells were expanded to reach 80% confluency in 100 mm 
dishes and washed with 1X PBS. After washing, the cells were trypsinized, collected in 
to 15 ml conical tubes and centrifuge at 1500 rpm for 2 minutes. The supernatant was 
aspirated and 1 ml of ice-cold freezing medium (95% FBS and 5% DMSO (Cat. No. 
D2650, Sigma, MO)) was added, mixed and 0.5 ml was added to each cryovial. The 
cryovials were then placed in Styrofoam racks (to slow down the freezing process) and 
transferred to -80oC freezer.  
To thaw cells, the frozen vial was placed in 37oC water bath briefly; cells were 
suspended in 5 ml DMEM +10% FBS +1% pen/strep and transferred to a 15 ml conical 
tube. The tube was centrifuged for 2 min at 1500 rpm and the supernatant was aspirated. 
10 ml fresh medium was added to the cell pellet, cells were plated in 100 mm dish and 
placed in 37oC humidified incubator supplemented with 5% CO2. The thawing process 
was carried out as fast as possible as DMSO present in the freezing medium is harmful to 
cells at higher temperatures. 
 
 
36 
3.4 RNA Interference (RNAi) 
HeLa cells (1x105) were plated in antibiotic-free medium and after 24 hours 
siRNA mediated transfection was done using Oligofectamine (Invitrogen, Carlsbad, CA) 
alone (mock) or mixed with a non-targeted siRNAs against luciferase (60 pmol; control; 
catalog no. D-001210-02; Dharmacon RNA Technologies) or with 60 pmoles Btf siRNA 
duplexes [siGENOME 1 (D-020734-01) target sequence: 
GAACAUAGUACUCGGCAAA; siGENOME2 (D-020734-02) target sequence: 
GGAAUGAGACGACCUUAUG; Dharmacon RNA Technologies, Lafayette, CO] or 60 
pmoles TRAP150 siRNA duplexes [siGENOME 1 (D-019907-01) target sequence: 
GGUAUAAGCUCCGAGAUGAUU and siGENOME 4 (D-019907-04) target sequence: 
GUUGAUCUCCGCCUUGAUAUU]. For double knockdown of Btf and TRAP150, the 
cells were transfected with BtfSi1 oligos (60 pmoles) and TRAPSi4 (60 pmoles).  
 
3.5 RNA Sample Preparation and real time quantitative PCR (qPCR) 
Total RNA extraction was performed according to the Qiagen RNAeasy (Qiagen) 
kit protocols. Briefly, cells cultured in 6 well dishes were trypsinized and collected by 
centrifuging for 5 min at 1500 rpm. The supernatant was completely aspirated and the 
cell pellet was resuspended in 350 µl buffer RLT. The cell suspension was homogenized 
by vortexing for 30 sec and 350 µl of 70% ethanol was added. 700 µl of the above 
solution was loaded into RNAeasy spin column placed in a 2 ml collection tube, 
centrifuged for 15 sec at full speed (13,200 rpm) and the flow through was discarded. 
700µl of buffer RW1 was added to the spin column, centrifuged for 15 sec at full speed 
and the flow through was discarded. The spin column was then washed 2 times with 500 
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µl of buffer RPE and centrifuged (first time for 15 sec and second time for 2 min) at full 
speed. To elute RNA, the spin column was placed in 1.7 ml collection tube, 30 µl RNase-
free water was added and the tube was centrifuged for 1 min at 14,000 rpm in an 
Eppendorf microcentrifuge. An optional elution step was performed by adding 30 µl of 
RNase-free water and collecting RNA in a fresh tube. Eluted RNA was stored at -80oC.  
 
3.6 DNase treatment 
The concentration of RNA extracted as described above, was measured using a 
Nanodrop spectrophotometer (Thermo Scientific). Buffer, Turbo DNase activation buffer 
(10%), 5 µg of RNA, Turbo DNase (1µl) were mixed and brought to 50 µl final volume 
with RNase free water. The samples were incubated at 37oC for 30 min followed by the 
addition of DNase inactivation reagent (10%) and incubated for 2 min at room 
temperature with occasional mixing. The samples were centrifuged for 1.5 min at 10,000 
X g and the supernatant containing DNA-free RNA was transferred to new 1.5 ml tubes 
and stored at -80oC. 
 
3.7 RT-PCR and quantitative RT-PCR 
RT-PCR was performed by using qScript-One step RT-PCR system and qScript-two step 
RT-PCR system (Quanta Biosciences, MD Cat. No. 95047, 95073). For one-step RT-
PCR, 100 ng of DNase treated RNA was used as template, 3 µM forward and reverse 
primers, 2X SybrGreen buffer, 1 µl reverse transcriptase and RNase-free water were used 
to make 10 µl reactions. Master mix was prepared by adding appropriate amounts of 
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SybrGreen buffer, reverse transcriptase, forward and reverse primers and water, mixed 
and centrifuged briefly and added to each of the tubes. 100 ng of RNA was added to each 
of the tubes and centrifuged briefly. The tubes were then loaded in Cephed one StepRT-
PCR machine (Chepheid, CA). Amplification was performed for 40 cycles. 
The quantitative results (ct values) of GAPDH qRT-PCR were subtracted from 
Btf/TRAP150 qRT-PCR results to determine Δct. ΔΔct was calculated by subtracting the 
effect of control siRNA. Fold change was then determined by calculating 2-ΔΔct. The 
average of the treated samples were plotted relative to the average of controls to represent 
the fold change in expression following SiRNA treatments. Standard deviation were 
calculated and shown as error bar. 
 
3.8 Immunofluorescence 
Hela cells were grown on glass coverslips in a 6-well dish and harvested at 50-60% 
confluency. Cells were washed with phosphate buffered saline (1XPBS; 18.3 mM 
Sodium phosphate monobasic, 84.5 mM Sodium phosphate dibasic, 1.45 M Sodium 
Chloride) and immediately fixed with 2% para-formaldehyde for 15 minutes at room 
temperature. After three washes with 1XPBS, the cells were then permeabilized with 
0.2% Triton X-100 (prepared in 1XPBS) for 5 minutes at room temperature. After three 
washes with phosphate buffered saline with normal goat serum (PBS/NGS), the cells 
were incubated in appropriate secondary antibodies conjugated with Texas Red or FITC. 
DAPI was added to the final PBS wash to label DNA. Primary antibodies used were Btf 
(WU10; 1:2500), TRAP150 (1:1000, Bethyl catalog number A300-956A). After three 
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washes with phosphate buffered saline with 0.5% normal goat serum (PBS/0.5% NGS), 
the cells were incubated in appropriate secondary antibodies conjugated with Texas Red, 
Cy5 or FITC (1:500; Jackson Immunoresearch Lab). DNA was stained with DAPI 
(10μg/ml). Finally, the coverslips were mounted in mounting medium (antifade poly- 
phenylenediamine medium) and sealed with a clear nail polish. 
 
3.9 Protein extraction 
The cells were removed from the plate by adding 5 ml cold PBS to the cells and 
scraping using a rubber policeman. The suspended cells were then placed in an eppendorf 
tube and centrifuged for 5 minutes at 4oC. Once the cells were centrifuged, they were 
resuspended in 100 μl of cold PBS and centrifuged for 2 minutes. Afterwards, the 
supernatant was removed and the pellet was resuspended in 100 μl of dH2O. The same 
amount of 2X Laemmli buffer (4% SDS, 20% glycerol, 1.4M β-mercaptoethanol, 0.125 
M Tris- HCl) was added to each sample. The samples were boiled at 100oC for 5 minutes. 
The samples were then stored for future immunoblotting analysis. 
 
 
3.10 Protein Quantification (Bradford Assay) 
Standards of known protein concentrations (0, 1, 2, 5 and 10 microgram) were 
prepared using bovine serum albumin (stock 10 μg/ μl). 5 μl of protein extract was mixed 
with 5 μl of 2x Laemmli. 490 μl of water and 500 μl of Coomassie Plus Protein Assay 
Reagent (Thermo Scientific) were added to each sample for a final volume of 1 ml. 
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Samples were loaded into 1 ml cuvettes and absorbance was measured at 595 
nanometers. A graph of OD versus μg protein was plotted with the standard samples and 
a best-fit line was used to calculate protein concentrations of experimental samples. 
 
3.11 SDS-PAGE and Immunoblotting 
The extracts with equal protein concentrations were loaded into the wells of a 7% 
gel. Precision Plus protein ladder (BioRad Catalog No. 161-0374) served as the 
molecular mass marker. The gel was run at 110V for one hour. The running buffer was 
prepared using 10X protein buffer (25mM Tris HCL, 190 mM glycine ) and 10 ml of 
10% SDS which was brought to a final volume of 1L. Once proteins were separated 
following electrophoresis, the proteins were then transferred from the polyacrylamide 
running gel to a nitrocellulose membrane at 200 mA for 90 minutes using chilled transfer 
buffer. Ponceau staining was used to confirm successful transfer (0.5% Ponceau S, 1% 
acetic acid) and to mark well lanes and mass markers. The nitrocellulose membrane was 
blocked against non-specific bonding using PBST ([0.22 M sodium phosphate 
monobasic, 1.2 M sodium phosphate dibasic anhydrous, 137 mM sodium chloride, and 
1.0% Tween) and 5% non-fat dry milk. The nitrocellulose paper was then cut into strips 
such that the upper portion (>100 kDa) was probed with rabbit anti-TRAP 150 (1:1000) 
or WU10 (1:1000) and the lower portion was probed with mouse anti-actin (1:1000). The 
antibodies were diluted in 5% nonfat dry milk prepared with 1X PBST. Primary 
antibodies were applied to the membrane and incubated for 1 hour. The membrane was 
washed 3 X 5 minutes with PBST on a rotary shaker. Afterwards, secondary antibodies 
were applied to the membrane and incubated for 1 hour at room temperature on a shaker. 
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Secondary antibodies used were anti- rabbit and anti-mouse horseradish peroxidase 
(HRP) (1:25,000). The membrane was then washed 3 X 5 minutes with PBST on a 
shaker. To detect species-specific antibodies conjugated with horseradish peroxidase 
(HRP) a chemiluminescence technique was used with Thermo Scientific Pierce ECL 
Western Blotting Substrate. The blot was then imaged on FUJI LAS-4000 Luminescent 
Image Analyzer (Fujifilm Life Science USA, Stamford, CT). 
 
3.12 Antibodies 
 For cell cycle progression experiments the following antibodies were used. 
TRAP150 antibody was purchased from Bethyl (1:1000; Cat. No. A300-956A), Anti-Btf 
antibody (1:1000), mouse anti-beta-actin (1:3000 for IF or WB), human anti-ACA 
antibody (1:3000 for IF), mouse anti-CENP-A (1:100 for IF), mouse anti-AURK-B 
(1:100 for IF and WB), mouse anti-MAD2 antibody (1:500 for IF and WB). 
 
3.13 Immunoprecipitation 
HeLa cells were cultured at 2 x 107 cells in a 100 mm dish. Cells were washed 
with 5 ml of 1X PBS and scraped off the plate using a rubber policeman and 1 ml 1X 
PBS. The cells were collected in 15 ml conical and spun at 2000 rpm for 5 min. The cell 
pellet was transferred into a 1.5 ml tube and spun at 2000 rpm for 2 min. Excess PBS was 
aspirated and 1 ml lysis buffer (300mM NaCl, 100mM Tris pH-8, 0.2mM EDTA, 
0.1%NP40, 10% glycerol, protease inhibitor cocktail) was added. Sample was placed in a 
rotator at 40 C for 45 mins. The lysate was then spun at 2000 rpm for 10 min. The 
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supernatant (whole cell extract) was collected and aliquoted in 3 tubes and snap frozen 
and stored at -80 C until use. 300 μl aliquots were diluted 3 fold with dilution buffer 
(100mM Tris pH-8, 0.2mM EDTA, 0.1% NP40, 10% glycerol, protease inhibitor 
cocktail) to dilute the concentration of the salt to 100 mM i.e .600 μl of ‘no salt’ IP buffer 
was added to achieve the final concentration of 100 mM NaCl concentration. This salt 
concentration is compatible with antigen/antibody interactions. Protein A coated agarose 
beads were added to the extract and incubated at 4oC for 30 min. This step is considered a 
preclearing step. Precleared beads were centrifuged at high speed at 4oC. Supernatant was 
used to prepare IP samples – Input (100 μl precleared WCNE), Extract (400 μl extract + 5 
μl Ab), No Ab (400 μl extract only), No extract (400 μl 100mM Nacl buffer +5 μl Ab). 
The appropriate primary antibody was added to the supernatant at specified dilution and 
rotated at 4oC with rocking for 90 minutes. 10-μl-bead volume of equilibrated protein A 
agarose beads was added, vortexed and incubated overnight at 4oC. This was followed by 
centrifugation at 16,000 g in a microfuge for 15 sec. Both bound and unbound fractions 
were saved for further examination. All samples containing beads were washed 5 times 
with 300 mM NaCl IP buffer. The higher salt concentration disrupts non-specific 
interactions of proteins in the extract with beads and also antibodies with cellular 
proteins. Centrifugation step was performed between each wash. Final wash was 
performed with 100mM NaCl. The lower salt concentration is compatible with the SDS-
PAGE. 100μl of 2X gel sample buffer (124 mM Tris HCL pH 6.8, 20% glycerol, 10% β-
mercaptoethanol, 4% SDS, 0.05% bromophenol blue) was added each of bound and 
unbound fraction. Each sample was boiled for 5 min, the beads were spun down by 
centrifugation at 14,000 x g for 10 min and the supernatants were resolved by 7% SDS-
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PAGE at 35 mA per gel for 1 hr. Proteins were transferred to nitrocellulose membranes 
for 2 hrs at 100V, 100 mA in 1 x transfer buffer (25mM Tris HCL, 190 mM glycine and 
20% methanol). Blots incubated with blocking buffer (5% donkey serum, 0.1% NaN3 in 
1X TBS-T) for 1 hr and then incubated in blocking solution with diluted primary 
antibody in blocking solution for 1 hr. After washing the membrane in PBS-T (PBS, 
0.1% Tween, pH 7.8) 3 times for 10 min each, the blots were incubated in solution 
containing secondary antibody conjugated to horseradish peroxidase in blocking solution 
for 1 hr followed by 3 washes 10 min each with TBS-T. Blots were then developed by 
incubating in Pierce, super signal west pico chemiluminescent substrate/ enhancer for 5 
min and then imaged with LAS 4000 Fuji by chemiluminescence. 
3.14 Silver Stain 
After electrophoresis, the SDS-PAGE gel was placed into a clean container with 
100 mL of fix solution (40% methanol, 10% acetic acid) and agitated on an orbital shaker 
for 20 minutes. Fix solution was poured off. 30% ethanol was added to the gel and 
agitated for 10 minutes. Ethanol was poured off and 100 mL sensitizing solution was 
added to the gel. The gel was washed with 100mL ultrapure water and incubated in 
100mL of staining solution for 15 minutes. After the staining is complete, the staining 
solution was decanted and the gel was washed with 100mL ultrapure water. The gel was 
incubated in 100 mL of developing solution and agitated for 4-8 minutes until the bands 
start to appear and the desired band intensity is achieved. After the appropriate staining 
was achieved, 10mL of stopper was added and agitated for 10 minutes. Prior to imaging, 
the gel was rinsed in 100mL ultrapure water two times for 5 minutes each. 
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CHAPTER 4: VALIDATION OF REGULATION OF MITOTIC CHECK 
POINT TRANSCRIPTS 
4.1 Btf and TRAP150 are essential for maintaining proper expression of cell  
cycle regulator transcripts. 
Affymetrix exon microarray analysis was performed previously on HeLa cells 
treated with Btf-siRNA duplexes (BtfSi1 and BtfSi2) or TRAP150-siRNA duplexes 
(TRAPSi4) compared to HeLa cells treated with control luciferase siRNA. Genes with 2-
fold or more differential gene expression were identified. For the microarray, Btf or 
TRAP150 depletion was confirmed in three replicate sets of siRNA treated samples by 
immunoblot; Btf and TRAP150 depletion was validated through qPCR as well as within 
the microarray data. 
Exon microarray analysis showed cell cycle to be the most significant pathway 
affected in both Btf or TRAP150-depleted samples, and mitotic checkpoint protein 
transcripts were up-regulated 2-fold or higher upon Btf and TRAP150 depletion (Table 
2). This upregulation of the mitotic checkpoint protein transcripts was validated by qRT-
PCR using different primer pairs targeting mitotic checkpoint gene transcripts (Table 3).  
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Table 2: Differentially expressed major chromosomal passenger genes  
after Btf and TRAP150 depletion in Affymetrix HumanExon10ST Array 
 
        Btf Si1        Btf Si2        TRAPSi4 
 FOLD 
CHANGE 
P-VALUE FOLD   
CHANG
E 
P-VALUE FOLD 
CHANG
E 
P-VALUE 
AURK-B 2.5 0.0002 1.7 0.003 2 0.001 
CENP-F 4.4 0.0002 3.4 0.0015 6.3 0.01 
BUB1 3.36 0.002 3.16 0.005 3.38 0.002 
CDK1 2.3 0.004 2.15 0.004 4.69 0.02 
CDC-20 3.38 0.003 2.37 0.0002 5.8 0.02 
MAD2L1 4.3 0.002 2.14 0.001 3.12 0.004 
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Table 3: Primer sequences for mitotic gene targets 
 
AURKB for 
AURKB rev 
GGCAAGAGAAAAGCAAAGCA 
TCTTCTGAGCTGATGCTCCA 
CENP-F for 
CENP-F rev 
GTGGCAACAGAAGCTGACAA 
TCTTCTGTGTCGATGCCAAG 
BUB1 for 
BUB1 rev 
AACTGAGCGCCATGTCTT 
CCAAAGGAACAACAGGA 
CDK1 for 
CDK1 rev 
GCCTTCTAATATCTCCCTTCG 
GCCATTCAATCGCTACCTCAT 
CDC-20 for 
CDC-20 rev 
ATGTGTGGCCTAGTGCTCCT 
TGATGCTGGGTGAATGTCTG 
MAD2L1 for 
MAD2L1 rev 
GTTCTTCTCATTCGGCATCAACA 
GAGTCCGTATTTCTGCACTCG 
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Validations by qRT-PCR (Figure 9) showed that Aurora-B mRNA was increased 
about 2-fold after Btf or TRAP150 depletion by Btf Si1, BtfSi2 and TRAPSi4 as 
compared to the control. CENP-F transcripts increased 4.4-fold in Btf-depleted samples 
by BtfSi1 and 3.4 fold in BtfSi2 treated samples, whereas the CENP-F transcripts in 
TRAP150-depleted samples were increased about 6-fold in TRAPSi4 samples. These 
results were consistent with the microarray data shown previously (displayed in Table 2). 
BUB1 transcripts increased about 3-fold in Btf-depleted samples after treatment with 
either BtfSi1 or BtfSi2 siRNA duplexes, whereas the BUB1 transcripts in TRAP150-
depleted samples treated wtih TRAPSi4 siRNA duplexeswere increased about 3-fold, 
consistent with the microarray data shown in Table 2. CDK1 transcripts increased about 
2-fold in Btf-depleted samples (BtfSi1, BtfSi2) whereas the CDK1 transcripts in 
TRAP150-depleted samples increased about 4-fold, consistent with microarray results 
shown in Table 2. CDC20 transcripts increased 3.3- fold in Btf-depleted samples by 
BtfSi1 and 2.3-fold in BtfSi2 treated samples consistent with microarray results whereas 
the CDC20 transcript level in TRAP150-depleted samples was increased 5.8-fold, 
consistent with the microarray data shown in the table. MAD2L1 transcripts increased 
4.3-fold in Btf-depleted samples by BtfSi1 and 2.1-fold in BtfSi2 treated samples 
consistent with microarray results whereas the MAD2L1 transcripts in TRAP150-
depleted samples was increased about 3-fold, consistent with the microarray data. 
Immunoblots and corresponding densitometry plots shows relative expression levels of 
Btf or TRAP150 in each of the three replicate samples used for transcript abundance 
validation by qRT-PCR (Figure 10). 
 This validates that key mitotic checkpoint transcripts identified in microarray data 
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analysis are in fact affected by Btf or TRAP150 depletion, and it suggests that the mitotic 
chromosomal defects that are observed upon Btf and TRAP150 depletion might be a 
consequence of misregulation of mitotic checkpoint gene transcripts by Btf and 
TRAP150. Validations of these genes have showed that Btf and TRAP150 have a role in 
regulation of mitotic progression. The specific mechanism underlying defective mitotic 
progression and chromosome alignment/segregation still needs to be understood. 
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Figure 9: Validation of upregulation for major checkpoint protein 
transcripts upon Btf or TRAP150 depletion 
RNA samples from control (60 pmoles; C), Btf (60 pmoles; BtfSi1, BtfSi2) or 
TRAP150 (60 pmoles; TRAPSi1, TRAPSi4) depleted cells were used for qRT-PCR 
analysis to validate alterations in transcripts that encode mitotic checkpoint proteins. 
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Figure 10: Immunoblots and corresponding densitometry plots showing 
relative expression levels of Btf or TRAP150 in three replicate samples.  
 Whole cell nuclear extracts from three replicate sets of HeLa cells transfected 
with Control siGenome2 targeting luciferase (control; 60 pmoles; C), Btf (60 pmoles; 
BtfSi1, BtfSi2) or TRAP150 (60 pmoles; TRAPSi1, TRAPSi4) were applied to SDS-
PAGE and immunoblotted using antibodies against Btf or TRAP150. Actin was used as a 
loading control.  Corresponding densitometry plots show lower signal intensity following 
treatment with siRNA duplexes targeting Btf and TRAP150 as compared to controls. 
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CHAPTER 5:  STUDYING MITOTIC DEFECTS 
FOLLOWING Btf AND TRAP150 DEPLETION 
Btf and/or TRAP150- depleted cells showed multiple mitotic defects at various 
mitotic stages. The most common defect was misaligned chromosomes in metaphase 
cells. This finding suggests that Btf and/TRAP150 may regulate spindle checkpoint 
activation. The spindle assembly checkpoint (SAC) ensures that all chromosomes are 
properly aligned at the metaphase plate before moving on to anaphase. The checkpoint 
gets activated when there are misaligned chromosomes and mitotic progression stops 
until this problem is fixed. Depletion of Btf and TRAP150 in HeLa cells increases the 
frequency of chromosome misalignment at metaphase. I hypothesized that altered 
abundance of cell cycle regulator mRNAs regulate mitotic progression, in particular 
affecting chromosome misalignment and that Btf and TRAP150 regulate abundance, 
processing and/or cellular distribution of cell cycle regulator transcripts and also suggest 
that Btf and TRAP150 impact mitosis indirectly (rather than directly) by altering cell-
cycle regulator transcripts. 
 To study the mitotic defects in Btf/TRAP 150 depleted samples, mitotic 
distribution and mitotic index were calculated in control, Btf or TRAP150-depleted cells, 
Btf and TRAP150 depleted cells. To calculate mitotic distribution, 500 mitotic cells of 
each sample (3 replicates performed) were scored and categorized into the different 
mitotic stages. Defective mitotic cells were also scored and categorized (Table 4 and 
 
56 
Figure 11 A).  The mitotic distribution and mitotic index was increased significantly in 
depleted samples as compared to the control samples. The mitotic stage most defective in 
Btf/TRAP150-deficient cells was metaphase (Figure 11 B). There was an increase in 
anaphase defects as well. The mitotic index was determined by counting the ratio 
between the number of cells in a population undergoing mitosis to the number of cells not 
undergoing mitosis. 
Mitotic index increased from 7% to 15.2% in Btf Si1 depleted cells and increased 
from 7% to 18.7% in Btf Si2 depleted cells, whereas, the mitotic index increased from 
7% to 17.9% in TRAP150Si1 and from 7% to 15.2% in TRAP150 Si4 depleted cells. Co-
depletion of Btf and TRAP150 showed an increased in mitotic index from 7% to 25.62% 
(Figure 11 A). This increase seen in the mitotic index in Btf/TRAP150-depleted cells 
suggests that the cells are either arresting at metaphase or cell cycle progression is 
delayed. The number of defective mitotic cells and metaphase chromosome misalignment 
defects was also increased in Btf/TRAP150 depleted cells when compared to control cells 
(Figure 11C).  
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Table 4: Depletion of Btf/TRAP150 causes increase in mitotic index 
 
500 cells of each sample (3 replicates performed) were scored and categorized 
according to mitotic stages 
 
 
Inter-
phase 
Pro-
phase 
Pro-
metap-
hase Metaphase Anaphase 
Telo-
phase 
Mitotic 
Index 
   N N D N D   
MOCK 469 2 8 7 4 2 - 7 6.6% 
CONTR-
OL 467 3 7 8 5 6 - 6 7.0% 
BtfSi1 434 7 10 11 16 5 3 14 15.20% 
BtfSi2 421 8 14 15 18 6 4 14 18.76% 
TRAPSi1 424 11 10 16 17 7 4 11 17.92% 
TRAPSi4 434 10 14 14 17 6 3 13 15.20% 
BtfSi1 
+ 
TRAPSi4 
 
398 
 
16 
 
17 
 
11 
 
26 
 
10 
 
7 
 
15 25.62% 
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Figure 11: Depletion of Btf/TRAP150 causes an increase in mitotic index 
 
A. Mitotic index was scored for HeLa cells treated with five different siRNA 
duplexes (BtfSi1, BtfSi2, TRAPSi1, TRAPSi4, BtfSi1+TRAPSi4), control siRNA 
duplexes and mock. 500 cells were scored per sample. 
B. From the same experiment, 500 cells in each condition (BtfSi1, BtfSi2, 
TRAPSi1, TRAPSi4, BtfSi1+TRAPSi4, control siRNA, mock) were scored for mitotic 
defects at different phases of mitosis. 
C. From a different experiment, 100 metaphase cells were scored for 
misalignment defects. 
N represents normal cells, D represents defects 
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5.2 To study the gene expression of mitotic checkpoint proteins. 
Validations by qRT-PCR showed that MAD2 mRNA increased about 4-fold, after 
Btf or TRAP150 depletion as compared to the control (Figure 9, yellow bars). Increased 
mRNA abundance is consistent with immunolocalization studies that showed an 
increased level of MAD2 at misaligned chromosomes during metaphase of Btf/TRAP150 
depleted cells.  Western blotting was performed to examine if changes in abundance of 
mitotic regulator MAD2 mRNA correlates with changes in their encoded proteins.  
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 Figure 12: Localization of MAD2 to misaligned chromosomes at metaphase  
in Btf-depleted cells 
A. HeLa cells were transfected with siRNA against control luciferase and Btf 
(using two siRNA duplexes; BtfSi1, BtfSi2) and TRAP150 (using two siRNA duplexes; 
TRAPSi1, TRAPSi4). 72 hrs. post transfection, the cells were processed for 
immunolocalization of Btf, TRAP150, ACA and MAD2. DNA was stained with DAPI.  
Misaligned chromosomes shown in BtfSi1, TRAPSi4, BtfSi1+TRAPSi4 depleted 
cells. 
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Figure 13: Immunoblots showing relative expression levels of MAD2 upon  
Btf/TRAP150 depletion. 
Equal amount of protein extract from control (C), Btf-depleted (B), TRAP-
depleted (T), or Btf- and TRAP150 co-depleted cells (BT) was applied to SDS-
PAGE and processed for immunoblotting with antibodies for Btf, actin, and mad2 
(left side) or TRAP150, actin and mad2 (right side).  Relative expression of mad2 
for each blot is shown at the bottom. 
Beta-actin was used as a loading control. 
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CHAPTER 6: TO IDENTIFY ENDOGENOUS PROTEIN BINDING 
PARTNERS OF Btf AND TRAP150  
  HeLa whole cell nuclear extracts were used to immunoprecipitate Btf and 
TRAP150 complexes. Btf and TRAP150 complexes that were immunoprecipitated from 
HeLa whole cell nuclear extracts showed multiple Btf and TRAP150 associated protein 
bands that were not present in the control immunoprecipitations.  
HeLa whole cell nuclear extracts were used for immunoprecipitation with Btf 
antibody (WU10) generated by the Bubulya lab. Immunoprecipitates were dissolved in 
Laemmli buffer and subjected to 7% SDS- PAGE and immunoblotted with polyclonal Btf 
antibody and TRAP150 antibody (aa930-956) for identifying Btf and TRAP150 
associated complexes respectively. Input is 10% of extract equivalent in the IP reaction, 
and is considered as the positive control to show presence of proteins at the start of the 
experiment (in the extract). Immunoprecipitates without antibody served as a control to 
detect non-specific binding of cellular proteins to beads. Precleared beads (PCB) contains 
materials bound to beads following preclearing of the input, that would include any 
proteins in the extract that have non-specific affinity for the protein A agarose. 
Immunoprecipitates with no extract served as a negative control for observing the bands 
in the immunoprecipitation that are attributed to antibody (IgG) bands or breakdown 
products (Figure 14).  Btf was detected at 150 KD and is indicated by arrow (lane3) 
showing Btf in the bound fraction of WU10 immunoprecipitates and input (compare lane 
2 and 3). The negative controls PCB and ‘no extract, bound’ fractions (lane 1 and lane 7, 
respectively) did not have Btf.  
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 Similarly, immunoprecipitation of TRAP150-associated complexes was 
performed using TRAP150 antibody (aa 930-955) using the same controls as described in 
Figure 15 for Btf immunoprecipitations (Figure 14).  
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 Figure 14: Immunoprecipitation of Btf to identify endogenous interacting  
Partners 
  HeLa whole cell nuclear extracts were used for immunoprecipitation. SDS-
PAGE was run and the immunoprecipitates [Bound (B) and unbound (UB) fraction] 
were analyzed by immunoblotting with anti-Btf (WU10). Btf was detected at 150 KD 
shown by arrow (lane3) showing Btf in the bound fraction of WU10 
immunoprecipitates and input (compare lane 2 and 3). The negative control no 
‘extract bound’ fraction (lane 7) did not have Btf. PCB - Precleared Beads, Lane I is 
the equivalent of 10% input. B indicates bound fraction and U indicates unbound 
fractions for each immunoprecipitate. 
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TRAP150 was detected at 150 KD and is indicated by an arrow (lane 3) showing 
TRAP in the bound fraction of anti-TRAP immunoprecipitates and input (compare lane 2 
and 3). The negative control no extract bound fraction (lane 7) did not have TRAP. PCB - 
Precleared Beads, Lane I is the equivalent of 10% input. B indicates bound fraction and 
U indicates unbound fractions for each immunoprecipitate. 
Silver staining was done to check if Btf and TRAP150 have some common and 
distinct binding partners (Figure 15 B). HeLa whole cell nuclear extracts were used for 
immunoprecipitation with Btf antibody (WU10, lane 4,)(Figure 15 B) and TRAP 
antibody (lane 9)(Figure 15 B). Immunoprecipitates without antibody and without 
extracts were served as a control to see non-specific binding of the proteins to beads 
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Figure 15: Immunoprecipitation of TRAP150 to identify endogenous  
interacting partners. 
A. HeLa whole cell nuclear extracts were used for immunoprecipitation. SDS-
PAGE was run and the immunoprecipitates (Bound and unbound fraction) were analyzed 
by immunoblotting with anti-TRAP. TRAP150 was seen at 150 KD shown by arrow 
(lane3) showing TRAP in the bound fraction immunoprecipitates and input (compare 
lane 2 and 3). The negative control no ‘extract bound’ fraction (lane 7) did not have Btf. 
PCB - Precleared Beads, Lane I is the equivalent of 10% input. B indicates bound 
fraction and U indicates unbound fractions for each immunoprecipitate. 
B. HeLa whole cell nuclear extracts were used for immunoprecipitation with Btf 
antibody (WU10, lane 4) and TRAP antibody (lane 9). Immunoprecipitates without 
antibody and without extracts were served as a control to see non-specific binding of the 
proteins to beads. Immunoprecipitates dissolved in Laemmli buffer was subjected to 7% 
SDS- PAGE and silver staining was performed as described in Methods. 
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CHAPTER 7: DISCUSSION 
 
           Pre-mRNA processing factors localize in small domains of the nucleus called 
nuclear speckles (Spector 1993). The location of speckles in close proximity with 
transcription sites suggests the role for speckles in gene expression. Btf and TRAP150 are 
two nuclear speckle proteins that are not well characterized (Mintz et al., 1999; Saitoh et 
al., 2004), and to know their functions in gene regulation will help in better 
understanding of regulation of protein coding transcripts. Btf and TRAP150 share a high 
degree of sequence similarity and identity in their primary amino acid sequence 
(Potabathula, D. 2009) but their role in mRNA processing is not known clearly.  
 Previous results from microarray data showed that Btf /TRAP150 depletion causes 
mitotic defects and altered abundance and splicing of some mRNAs, specifically cell 
cycle regulator transcripts. I have used qPCR to validate the microarray results that 
showed the altered mitotic checkpoint protein transcripts (i.e. up-regulation of 2-fold or 
higher) upon Btf and TRAP150 depletion. qRT-PCR was done busing different primer 
pairs targeting mitotic checkpoint gene transcripts (AURK-B, CENP-F, BUB1, CDK1, 
CDC-20 and MAD2L1) on total RNA isolated from 3 replicate samples of Btf and 
TRAP150 depleted samples.  Immunoblot analysis showed efficient depletion of Btf or 
TRAP150. Validation of the mitotic check point transcripts identified in microarray data 
suggests that the mitotic defects observed upon depletion of Btf/TRAP150 might be 
because of the misregulation of mitotic checkpoint protein transcripts. Some of the other 
gene transcripts that were validated previously from the Bubulya lab include AURK-B, 
CENP-E, BUB-1B, NDC 80 and CENP-F. 
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  Previous studies on co-localization showed that Btf and/or TRAP150 show 
extensive overlap with SRSF1 at the U2OS 2-6-3-reporter locus (Varia et al., 2013). This 
suggests that Btf and/or TRAP150 might share similar roles with SRSF1 in splicing. 
Exon array analysis also showed defects in alternative splicing of certain cell cycle 
regulators upon Btf or TRAP150 depletion. Validations of those genes in the future might 
show the role of Btf and TRAP150 in regulation of mitotic progression and alternative 
splicing of specific endogenous cell cycle gene transcripts as demonstrated from the exon 
array data. Specific mechanisms underlying defective mitotic progression and 
chromosome alignment/segregation also need to be elucidated. 
               Previous work from the Bubulya lab showed no co-localization between both 
Btf /TRAP150 and any mitotic structure, which suggests that Btf/TRAP150 most likely 
affects mitosis in an indirect way. Btf/TRAP150 depletion studies were done in order to 
understand the cause of mitotic defects.  Btf/TRAP150 depleted cells showed mitotic 
defects at various mitotic stages and a greater number of metaphase defects were seen 
when compared to control samples. The most common mitotic defect found was 
misaligned chromosomes in metaphase stage of mitosis. To further understand the mitotic 
defect and to see if any particular mitotic phases showed abnormal chromosomal 
structures, I calculated mitotic distribution in control and Btf/TRAP150 depleted cells. 
The mitotic stages that were most affected in Btf/TRAP150-deficient cells was 
metaphase. A few anaphase defects were also found. This suggests that Btf/TRAP150 
regulate spindle assembly checkpoint activation by controlling the levels of chromosomal 
passenger proteins or via processing/regulation of their corresponding mRNAs, since 
proper alignment of chromosomes during metaphase is regulated by the spindle assembly 
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checkpoint (SAC). The SAC ensures proper chromosome segregation by preventing 
anaphase onset until all chromosomes are properly attached to microtubules that align 
chromosomes at the metaphase plate. Improperly attached kinetochores emit signals that 
activate the SAC, which in turn stops the cell cycle by negatively regulating CDC20, 
thereby preventing the activation of the anaphase promoting complex (APC) by 
recruiting a complex of checkpoint proteins that inhibits the actions of the APC (Shah 
and Cleveland, 2000). Btf and TRAP150 overlap with each other in many functions. 
Some of the specific cell-cycle target transcripts might overlap with both Btf/TRAP150. 
Also, previous results showed that TRAP150 depletion results in upregulation of Btf and 
Btf depletion results in the upregulation of TRAP150.  Btf and TRAP150 have 
compensatory roles, so it is possible that depletion of one protein might be compensated 
by the upregulation of the other. Thus, to overcome this we have co-depleted both Btf 
and TRAP150 in order to detect significant defects in the misalignment of chromosomes 
at metaphase. Co-depletion of Btf and TRAP150 has shown increased effects on the 
misalignment of chromosomes at metaphase of mitosis. Further studies can be done to 
measure the interkinetochore distances of unattached versus attached chromosomes; 
tension induced by microtubule attachment to the kinetochore can be studied to further 
understand if chromatids that appear misaligned versus aligned chromosomes are 
attached or detached from the mitotic spindle. 
 I have also tested whether the spindle checkpoint protein (MAD2) is recruited to 
the misaligned chromosomes. Localization of mitotic checkpoint protein MAD2 was 
analyzed at kinetochores of the misaligned chromosomes following Btf and/or TRAP150 
depletion. If the checkpoint is active, the mitotic checkpoint proteins should localize to 
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the kinetochores of misaligned chromosomes. Immunofluorescence showed that MAD2 
localized with higher intensities at some misaligned chromosomes as compared to the 
aligned chromosomes at metaphase in Btf and/or TRAP150 depleted cells. This was 
consistent with immunoblot data and densitometry analysis that showed increased protein 
expression of MAD2 in Btf and/or TRAP150 depleted cells as compared to control. Thus, 
these localization studies indicated that the checkpoint proteins are able to recognize and 
localize to the misaligned chromosomes in Btf- or TRAP150-depleted cells. Further 
quantitative imaging studies need to be done to understand and differentiate the 
intensities of MAD2 localization at aligned vs misaligned chromosomes. We expect that 
overexpression of the mitotic checkpoint genes could lead to similar defects, as this 
would potentially increase their abundance at kinetochores at metaphase as observed in 
Btf and/or TRAP150 depleted cells.  Increased abundance of MAD2 at kinetochores 
observed in my studies must be further evaluated, especially to learn if this prevents 
mitotic progression or not. 
 Previous work in Bubulya lab showed that Btf/TRAP150 co-localize with SRSF1 
and EJC component Magoh at transcription sites; and depletion of Btf/TRAP150 causes 
mitotic defects and altered abundance and splicing of some mRNAs that include cell 
cycle regulator transcripts  (Varia et al., 2013). Btf and TRAP150 also were co-
immunoprecipitated with exon junction complex (EJC) proteins (Lee et al., 2010; Varia 
et al., 2013). Identification of Btf and/or TRAP150 in various mRNA processing factor 
complexes such as exon junction complex reveals their function in mRNA processing. 
Immunoprecipitation was performed to identify if WU10 (anti-Btf antibody) and anti-
TRAP150 antibody can pull down Btf and TRAP150 in HeLa extracts respectively. 
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Optimization was done using different dilutions of antibody to effectively pull down Btf 
and TRAP150. Immunoblot results showed that Btf and TRAP150 were effectively 
pulled down by WU10 and anti-TRAP150 antibody in the bound fraction of 
immunoprecipitates respectively. Sister SDS-PAGE gels run side-by-side with either the 
Btf or TRAP150 immunoprecipitates along with silver staining were all done to confirm 
pulldown of proteins of interest as well as to identify the interacting partners of Btf and 
TRAP150.  The results showed some of the binding partner bands are common between 
Btf and TRAP150 while there are some partners unique to Btf or TRAP150. Mass 
spectrometry analysis will be done to identify the interacting partners. This will help in 
future to not only identify the interacting proteins of Btf and TRAP150, but also to 
understand their exact function in mRNA processing and differences in mRNA regulation 
by Btf versus TRAP150. 
 The Bubulya lab generated a polyclonal antiserum (WU10) that was directed 
against the peptide ERPSTTKDKHKEEDKNS located near the C-terminus of Btf. This 
peptide sequence is not found in TRAP150. Co-Immunoprecipitation can be done to 
check if Btf and TRAP150 are in the same complex. Further studies needs to be done to 
understand the interaction of these two homologous proteins to see if they are in a 
direct/indirect interaction with a scaffold of proteins. In addition, if they are in the same 
complex it must be ruled out that the apparent co-IP is not simply due to adjacent EJC 
complexes along mRNAs being pulled down as a result of intact mRNA in the extract.  
RNase treatment of extracts will be done in the future to rule out this possibility.  
 Previous experiments to test the global effects on mRNA demonstrated that 
depletion of Btf, but not TRAP150, caused accumulation of polyadenylated RNA in the 
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cytoplasm of HeLa cells (Varia et al., 2013). This shows distinct functions of Btf and 
TRAP150 in regulating the cellular distribution of mRNA, whereas, depletion of Btf 
and/TRAP150 causes misalignment of chromosomes at metaphase of mitosis. This shows 
that Btf and TRAP150 might share an overlapping function in cell cycle that is not shared 
with regard to mRNA export/stability/localization. Identification of common and distinct 
binding protein partners will shed light on other overlapping and distinct functions of Btf 
and/or TRAP150, and it will also help us to understand the connection between 
Btf/TRAP150 in misregulation of cell-cycle regulator transcripts and cell-cycle regulator 
proteins. 
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ABBREVIATIONS 
 
APC – Anaphase promoting complex 
ATP – Adenosine triphophate 
AURK-B – Aurora Kinase-B 
BUB – Budding uninhibited by benzimidazole 
cDNA – complementary DNA 
CENP – Centromere associated protein 
CDK1 - Cyclin dependent kinase 
CDC-20 - Cell-division cycle   
CTD - Carboxy-terminal domain  
DMEM – Dulbecco’s modified Eagle’s medium 
DNA – Deoxyribonucleic acid 
DTT – Dithiothreitol 
EJC – Exon Junction Complex 
EDTA – Ethylenediamine tetra-acetic acid 
FBS – Fetal bovine serum 
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GTP – Guanosine Triphosphate 
MAD – Mitotic arrest deficiency 
MCC – Mitotic checkpoint complex 
mRNPs - Mature messenger ribonucleoproteins  
PBS – Phosphate buffered saline 
PCR – Polymerase chain reaction 
RNA – Ribonucleic acid 
SAC – Spindle Assembly checkpoint 
SR - Serine-arginine-rich  
 
 
 
